The high affinity IgE receptor, FcepsilonRI, is comprised of an IgE-binding alpha chain and betagamma2 signaling subunits. FcepsilonRI controls allergic mediator secretion in mast cells. FcepsilonRIbeta topology and function are unique among human antigen receptors. Dr. Kinet and his colleagues have found that beta acts as an amplifier at two levels: 1) beta amplifies FcepsilonRI regulated signaling events in vitro and in vivo . 2) beta potentiates FcepsilonRI surface expression. They have identified a novel beta splice variant (betaT), which is co-expressed with wild-type (WT) beta, has a short half-life, and negatively regulates of FcepsilonRI surface expression. They will explore the molecular mechanisms behind the signaling and expression amplification functions of beta, and the receptor down regulation due to betaT. First, they will elucidate the signal amplification mechanism of beta. They will test the hypothesis that the signal amplifier function is due to the protein-protein interactions of the beta N- and C-termini. They will study whether the atypical structure of the ITAM signaling motif in the beta C-terminus, bears upon this role of beta, and test the hypothesis that beta N-terminus contributes to Lyn kinase activation/deactivation. Second, Dr. Kinet will elucidate the mechanism of expression amplification function by beta. They hypothesize that this amplification depends on interactions between alpha and beta in the ER. They will characterize the regions in alpha and beta that interact, and assay whether these interactions participate in beta expression amplifier function. Third, they will address the mechanism of action of betaT, which, in contrast to WT beta, is a negative regulator of FcepsilonRI. They will address 1) how betaT, affects levels of intracellular and mature FcepsilonRI subunits, 2) whether betaT and betaWT compete for nascent alpha chains in the ER, and 3) whether the short half-life of betaT reflects targeting of betaT and associated proteins to the proteasome. Finally, Dr. Kinet hypothesizes that the relative expression levels of betaT and WT beta may alter the allergic status of an individual, since expression of betaT severely alters FcepsilonRI expression on cells, and will change the intensity of their antigen responses. He will investigate 1) whether there are differences between individuals in the betaWT/betaT ratio, and 2) whether these differences correlate with allergic status.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM053950-06
Application #
6386256
Study Section
Special Emphasis Panel (ZRG1-IMS (01))
Program Officer
Marino, Pamela
Project Start
1996-04-01
Project End
2004-04-30
Budget Start
2001-05-01
Budget End
2002-04-30
Support Year
6
Fiscal Year
2001
Total Cost
$348,000
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Vig, Monika; Kinet, Jean-Pierre (2009) Calcium signaling in immune cells. Nat Immunol 10:21-7
Vig, Monika; DeHaven, Wayne I; Bird, Gary S et al. (2008) Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels. Nat Immunol 9:89-96
Vig, Monika; Beck, Andreas; Billingsley, James M et al. (2006) CRACM1 multimers form the ion-selective pore of the CRAC channel. Curr Biol 16:2073-9
On, Marina; Billingsley, James M; Jouvin, Marie-Helene et al. (2004) Molecular dissection of the FcRbeta signaling amplifier. J Biol Chem 279:45782-90
Lantz, C S; Yamaguchi, M; Oettgen, H C et al. (1997) IgE regulates mouse basophil Fc epsilon RI expression in vivo. J Immunol 158:2517-21
Yamaguchi, M; Lantz, C S; Oettgen, H C et al. (1997) IgE enhances mouse mast cell Fc(epsilon)RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med 185:663-72
Fleming, T J; Donnadieu, E; Song, C H et al. (1997) Negative regulation of Fc epsilon RI-mediated degranulation by CD81. J Exp Med 186:1307-14
Dombrowicz, D; Flamand, V; Miyajima, I et al. (1997) Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains. J Clin Invest 99:915-25